Artificial intelligence specialist Owkin has added another piece to its medical research portfolio with the launch of ...

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical ...

"Many loss of pulse incidents happen when the person is alone, leaving them with effectively no chance of receiving ...

OKN4395 is the first Owkin development program to leverage K1.0, Owkin’s AI-powered Operating System, from asset selection to clinical development optimization This asset is a highly selective ...

Oncology researcher Pierce works at Owkin, a Paris-based biotech with a modest goal for AI, he says with a laugh: To double the chances of drug development success from the industry standard of ...

Comedian Chloe Fineman's beloved Shiba Inu, Peach, is trading in his extra fluff for a healthier lifestyle. Fineman has ...

Research led by York University's Faculty of Health reveals how a specific mutation in a protein called TRAF1 can shut down an overactive immune response, dramatically reducing inflammation in mice.

Late Sunday local time, French president Emmanuel Macron announced a total of €109 billion in private investments in the AI ...

AI in Healthcare Market SizeThe global artificial intelligence (AI) in healthcare market was worth USD 32.51 billion in 2024 ...

French President Emmanuel Macron announced a total of €109 billion in private investments in the AI ecosystem (around $112 billion at current exchange rates) on Sunday evening. This week, Paris is ...

Based on this report, two important areas for AI startups in France are health and climate. Owkin and its spinoff biotech company Bioptimus have been leading the pack on the health tech front ...